NASDAQ: KOD · Life Sciences · 8 alerts · CIK 1468748
Share price
$100.73Close, Nov 16
Market cap
$6.59B
Shares outstanding
65.4MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Kodiak Sciences Inc. filings on SEC EDGAR ↗
Kodiak Sciences Director Baker Bros. Advisors LP Buys $24.3M of Stock
Baker Bros. Advisors LP, Director, bought 247,090 shares of Kodiak Sciences Inc. at $98.51 a share, worth $24.3M in total between Nov 4, 2026 and Nov 5, 2026. Shares held after the trade: 20,424,859 (+0.4%).
Kodiak Sciences Director Baker Bros. Advisors LP Buys $63.4M of Stock
Baker Bros. Advisors LP, Director, bought 715,508 shares of Kodiak Sciences Inc. at $84.24 to $89.86 a share (average $88.59) in 21 transactions, worth $63.4M in total between Sep 28, 2026 and Sep 29, 2026. Shares held after the trade: 19,772,333 (+0.5%).
Kodiak Sciences Director Baker Bros. Advisors LP Buys $34.9M of Stock
Baker Bros. Advisors LP, Director, bought 418,105 shares of Kodiak Sciences Inc. at $79.40 to $85.97 a share (average $83.58) in 26 transactions, worth $34.9M in total on Sep 28, 2026. Shares held after the trade: 19,153,010 (+0.0%).
Kodiak Sciences Director Baker Bros. Advisors LP Buys $58.6M of Stock
Baker Bros. Advisors LP, Director, bought 807,840 shares of Kodiak Sciences Inc. at $61.21 to $78.57 a share (average $72.57) in 30 transactions, worth $58.6M in total on Sep 28, 2026. Shares held after the trade: 18,435,276 (+0.0%).